All terms in GO
| Label | Id | Description |
|---|---|---|
| pole plasm | GO_0045495 | [Differentiated cytoplasm associated with a pole (animal, vegetal, anterior, or posterior) of an oocyte, egg or early embryo.] |
| Ku-DNA ligase complex | GO_0070420 | [A nonhomologous end joining complex that contains one or more Ku monomers and one or more DNA ligase molecules from the LigC or LigD family, and mediates nonhomologous end joining in bacteria.] |
| nonhomologous end joining complex | GO_0070419 | [A protein complex that plays a role in DNA double-strand break repair via nonhomologous end joining. Such complexes typically contain a specialized DNA ligase (e.g. Lig4 in eukaryotes) and one or more proteins that bind to DNA ends.] |
| DNA ligase III-XRCC1 complex | GO_0070421 | [A protein complex that contains DNA ligase III and XRCC1, and is involved in base excision repair.] |
| sex comb development | GO_0045498 | [The process whose specific outcome is the progression of the sex comb over time, from its formation to the mature structure. The sex combs are the male specific chaetae located on the prothoracic tarsal segment of the prothoracic leg.] |
| G-protein beta/gamma-Raf-1 complex | GO_0070422 | [A protein complex formed by the association of the serine-threonine protein kinase Raf-1 with the beta and gamma subunits of a heterotrimeric G protein.] |
| chemorepellent activity | GO_0045499 | [Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a lower concentration of that signal.] |
| nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | GO_0035872 | [A series of molecular signals generated as a consequence of a nucleotide-binding domain, leucine rich repeat containing receptor (NLR) binding to one of its physiological ligands. NLRs are cytoplasmic receptors defined by their tripartite domain architecture that contains: a variable C-terminus, a middle nucleotide-binding domain, and a LRR domain that is variable in the repeats composition and number. The NLR signaling pathway begins with binding of a ligand to a NLR receptor and ends with regulation of a downstream cellular process.] |
| cytoplasmic pattern recognition receptor signaling pathway | GO_0002753 | [Any series of molecular signals generated as a consequence of a cytoplasmic pattern recognition receptor (PRR) binding to one of its physiological ligands. PRRs bind pathogen-associated molecular pattern (PAMPs), structures conserved among microbial species, or damage-associated molecular pattern (DAMPs), endogenous molecules released from damaged cells.] |
| negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | GO_0070429 | [Any process that stops, prevents, or reduces the frequency, rate, or extent of the nucleotide-binding oligomerization domain containing 1 (NOD1) pathway.] |
| photoreceptor cell maintenance | GO_0045494 | [Any process preventing the degeneration of the photoreceptor, a specialized cell type that is sensitive to light.] |
| protein pupylation | GO_0070490 | [The process in which a Pup protein is conjugated to a target protein via an isopeptide bond between the carboxy-terminus of Pup and the epsilon-amino group of a lysine residue of the target protein.] |
| protein modification by small protein conjugation | GO_0032446 | [A protein modification process in which one or more groups of a small protein, such as ubiquitin or a ubiquitin-like protein, are covalently attached to a target protein.] |
| repressing transcription factor binding | GO_0070491 | [Interacting selectively and non-covalently with a transcription repressor, any protein whose activity is required to prevent or downregulate transcription.] |
| DNA-binding transcription factor binding | GO_0140297 | [Interacting selectively and non-covalently with a DNA-binding transcription factor, a protein that interacts with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription.] |
| thrombin-activated receptor signaling pathway | GO_0070493 | [The series of molecular signals generated as a consequence of a thrombin-activated receptor binding to one of its physiological ligands.] |
| regulation of thrombin-activated receptor signaling pathway | GO_0070494 | [Any process that modulates the frequency, rate or extent of a thrombin-activated receptor signaling pathway activity. A thrombin receptor signaling pathway is the series of molecular signals generated as a consequence of a thrombin-activated receptor binding to one of its physiological ligands.] |
| negative regulation of thrombin-activated receptor signaling pathway | GO_0070495 | [Any process that stops, prevents, or reduces the frequency, rate or extent of thrombin-activated receptor protein signaling pathway activity. A thrombin receptor signaling pathway is the series of molecular signals generated as a consequence of a thrombin-activated receptor binding to one of its physiological ligands.] |
| positive regulation of thrombin-activated receptor signaling pathway | GO_0070496 | [Any process that activates or increases the frequency, rate or extent of thrombin-activated receptor protein signaling pathway activity. A thrombin receptor signaling pathway is the series of molecular signals generated as a consequence of a thrombin-activated receptor binding to one of its physiological ligands.] |
| 6-carboxy-5,6,7,8-tetrahydropterin synthase activity | GO_0070497 | [Catalysis of the reaction: 7,8-dihydroneopterin triphosphate + H2O = 6-carboxy-5,6,7,8-tetrahydropterin + triphosphate + acetaldehyde + 2 H+.] |